Showing 5131-5140 of 10638 results for "".
How COVID-19 Is Affecting Life Outside of the Office: A Dermatologist’s Experience
https://reachmd.com/programs/covid-19-frontlines/how-covid-19-is-affecting-life-outside-of-the-office-a-dermatologists-experience/11363/Community support and outlets are becoming increasingly important during the COVID-19 pandemic. Here are some you can take advantage of.Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
https://reachmd.com/programs/project-oncology/growth-recovery-after-tovorafenib-in-pediatric-low-grade-gliomas/37196/As tovorafenib use expands in children with BRAF-altered low-grade gliomas, new data offer critical insight into one of its key safety considerations: growth suppression. Based on post hoc findings from multiple studies, most patients who experienced growth suppression during treatment demonstratedThe Belly and the Brain: Weight Management and Headache
https://reachmd.com/diseases-diagnoses/headache-pain/the-belly-and-the-brain-weight-management-and-headache/39225/Jennifer Williams McVige, MD, Director of the DENT Concussion Institute and Attending Neurologist at the DENT Neurologic Institute, Buffalo, NY, discusses the clinical evidence linking weight management with the improvement of headache symptoms and outlines practical strategies—including diet and exWhat Are the Latest Advances in Lupus Care?
https://reachmd.com/programs/conference-coverage/what-are-the-latest-advances-in-lupus-care/10308/Although nonrenal lupus patients face a variety of challenges, there’s fortunately been a lot of advances in care, as outlined by a guru in lupus.Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
https://reachmd.com/programs/neurofrontiers/Data-Equity-in-Action-Largest-Real-World-MS-Analysis-Confirms-Fumarate-Efficacy-Across-Racial-Groups/36351/The Impact of ECTRIMS Over 40 Years
https://reachmd.com/programs/neurofrontiers/the-impact-of-ectrims-over-40-years/26378/Hear from Dr. Mar Tintoré on what to expect from this year’s ECTRIMS conference.Updates to the Diagnostic Criteria for MS Patients
https://reachmd.com/programs/neurofrontiers/updates-to-the-diagnostic-criteria-for-ms-patients/26379/What are the updates for MS patients?Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
https://reachmd.com/clinical-practice/nephrology/implications-of-the-fine-one-trial-how-might-recently-presented-data-from-the-2025-kidney-meeting-influence-the-current-treatment-paradigm-for-type-1-diabetes-and-ckd/39958/Dr. Pratley evaluates recent data from the FINE-ONE trial and explains the relevance of these findings to clinical practice.The Metabolic Roots of Early-Onset Colorectal Cancer
https://reachmd.com/programs/project-oncology/metabolic-roots-early-onset-crc/49166/Moving Beyond Correction: WCO’s Standard of Care for Myopia Management
https://reachmd.com/programs/eye-on-ocular-health/moving-beyond-correction-wcos-standard-of-care-for-myopia-management/36284/Myopia is more than blurred vision; it's a chronic condition requiring lifelong attention that could affect up to five billion people by 2050. In response to this growing crisis, the World Council of Optometry (WCO) has issued standard-of-care guidelines built around three pillars: Mitigation, Measu